AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32183768 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 550
Study 32183768 — intervention group
Group type: EXPERIMENTAL
Intervention: Eurythmy therapy (EYT) and Tai Chi
Number of subjects: 550
Study 36107586 — intervention group
Group type: EXPERIMENTAL
Intervention: Double operator technique
Number of subjects: 47
Study 36107586 — intervention group
Group type: COMPARATOR
Intervention: Single operator technique
Number of subjects: 47
Study 36107586 — intervention group
Group type: COMPARATOR
Intervention: Single operator techniques
Number of subjects: 47
Study 33245905 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy
Number of subjects: 0
Study 33245905 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitor (ACEI) therapy
Number of subjects: 0
Study 33245905 — intervention group
Group type: EXPERIMENTAL
Intervention: Target dosing of beta-blocker and ACEI therapy
Number of subjects: 0
Study 32819445 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined group (IV-TXA 15 mg/kg + local TXA 2 g)
Number of subjects: 280
Study 32819445 — intervention group
Group type: EXPERIMENTAL
Intervention: IV group (IV-TXA 15 mg/kg)
Number of subjects: 280
Study 32819445 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical group (local TXA 2 g)
Number of subjects: 280
Study 32819445 — intervention group
Group type: COMPARATOR
Intervention: Control group (100 mL IV)
Number of subjects: 280
Study 32819445 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 280
Study 35557091 — intervention group
Group type: COMPARATOR
Intervention: Standardized Patient (STP)
Number of subjects: 66
Study 35557091 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity Human Patient Simulation (HPS)
Number of subjects: 66
Study 35557091 — intervention group
Group type: COMPARATOR
Intervention: Didactic Lecture
Number of subjects: 66
Study 35557091 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Learning Environments (Didactic, STP, HPS)
Number of subjects: 66
Study 33557988 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention to improve hand hygiene compliance
Number of subjects: 0
Study 35980383 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention program consisting of two supervised resistance exercise sessions per week plus individual aerobic exercise recommendations for 8 weeks.
Number of subjects: 32
Study 35980383 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention program
Number of subjects: 32
Study 33048875 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination prevention intervention with universal ART (Arm A)
Number of subjects: 200
Study 33048875 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention intervention with ART provided according to local guidelines (Arm B)
Number of subjects: 200
Study 33048875 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (Arm C)
Number of subjects: 200
Study 33138177 — intervention group
Group type: EXPERIMENTAL
Intervention: ERT-based model for estimating Rs values using routine meteorological observations (2000-2015)
Number of subjects: 756
Study 33138177 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term variation trends of Rs at 454 stations (1970-2015)
Number of subjects: 756
Study 33138177 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term variation trends of Rs during 1970-1992
Number of subjects: 756
Study 33138177 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term variation trends of Rs during 1992-2015
Number of subjects: 756
Study 33138177 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery trends at individual stations during 1970-2015
Number of subjects: 756
Study 34081487 — intervention group
Group type: EXPERIMENTAL
Intervention: CDI-only
Number of subjects: 528
Study 34081487 — intervention group
Group type: EXPERIMENTAL
Intervention: CDI plus PNF-only booster
Number of subjects: 528
Study 34081487 — intervention group
Group type: EXPERIMENTAL
Intervention: CDI plus PNF and PBS feedback booster
Number of subjects: 528
Study 34081487 — intervention group
Group type: COMPARATOR
Intervention: All conditions
Number of subjects: 528
Study 34940806 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV20
Number of subjects: 1000
Study 34940806 — intervention group
Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 1000
Study 34940806 — intervention group
Group type: COMPARATOR
Intervention: PPSV23
Number of subjects: 1000
Study 32997825 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF A and VEGFR2 gene polymorphisms
Number of subjects: 273
Study 32997825 — intervention group
Group type: COMPARATOR
Intervention: Control group (100 healthy blood donors)
Number of subjects: 273
Study 32773450 — intervention group
Group type: COMPARATOR
Intervention: Myostatin inhibitors
Number of subjects: 0
Study 35347399 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneological treatment (peloidotherapy + hydrotherapy)
Number of subjects: 64
Study 35347399 — intervention group
Group type: COMPARATOR
Intervention: Control group (peloid applied over a stretch film cover)
Number of subjects: 64
Study 35347399 — intervention group
Group type: COMPARATOR
Intervention: Both groups (balneological treatment and control)
Number of subjects: 64
Study 33971731 — intervention group
Group type: EXPERIMENTAL
Intervention: Services from a multidisciplinary team that includes integrated supported employment
Number of subjects: 2960
Study 33971731 — intervention group
Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 2960
Study 33971731 — intervention group
Group type: EXPERIMENTAL
Intervention: Services from a similar team that includes a nurse care coordinator for medication management support and medical care
Number of subjects: 2960
Study 32603613 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.1 GBq I‐131
Number of subjects: 160
Study 32603613 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.7 GBq I‐131
Number of subjects: 160
Study 32603613 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 160
Study 35629233 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron (0.3 mg after anesthetic induction)
Number of subjects: 56
Study 35629233 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 56
Study 32335950 — intervention group
Group type: COMPARATOR
Intervention: 0.0 mg oestradiol benzoate (0EB group; n=12)
Number of subjects: 36
Study 32335950 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg oestradiol benzoate (0.5EB group; n=12)
Number of subjects: 36
Study 32335950 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg oestradiol benzoate (1.0EB group; n=12)
Number of subjects: 36
Study 32335950 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 36
Study 35142535 — intervention group
Group type: EXPERIMENTAL
Intervention: BTL-TML (low-dose Thimerosal)
Number of subjects: 22
Study 35142535 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 22
Study 34006462 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality intervention
Number of subjects: 78
Study 34006462 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 78
Study 32828837 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospectively registered trials
Number of subjects: 196
Study 32828837 — intervention group
Group type: COMPARATOR
Intervention: Retrospectively registered trials
Number of subjects: 196
Study 32828837 — intervention group
Group type: EXPERIMENTAL
Intervention: Trials with non-significant difference between treatments for primary outcome
Number of subjects: 196
Study 32828837 — intervention group
Group type: EXPERIMENTAL
Intervention: Registered trials
Number of subjects: 196
Study 35334605 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music during colposcopy (Group 1)
Number of subjects: 240
Study 35334605 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music, no headphones)
Number of subjects: 240
Study 35334605 — intervention group
Group type: EXPERIMENTAL
Intervention: Colposcopy while wearing headphones but not listening to music (Group 2)
Number of subjects: 240
Study 33388816 — intervention group
Group type: EXPERIMENTAL
Intervention: Left arm group (no visual feedback)
Number of subjects: 40
Study 33388816 — intervention group
Group type: EXPERIMENTAL
Intervention: Right arm group (with increasing task experience and sensory information)
Number of subjects: 40
Study 33388816 — intervention group
Group type: EXPERIMENTAL
Intervention: Left arm group (with increasing task experience and sensory information)
Number of subjects: 40
Study 33306419 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-Promoting Lifestyle Education Program
Number of subjects: 88
Study 33306419 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 88
Study 35106942 — intervention group
Group type: EXPERIMENTAL
Intervention: HealthyMoms app
Number of subjects: 305
Study 32816324 — intervention group
Group type: EXPERIMENTAL
Intervention: High tibial osteotomy (HTO)
Number of subjects: 24
Study 32816324 — intervention group
Group type: COMPARATOR
Intervention: Control group (48 older healthy participants)
Number of subjects: 24
Study 36196533 — intervention group
Group type: EXPERIMENTAL
Intervention: External coaching
Number of subjects: 75
Study 36196533 — intervention group
Group type: COMPARATOR
Intervention: No coaching (control)
Number of subjects: 75
Study 36196533 — intervention group
Group type: EXPERIMENTAL
Intervention: External coaching and No coaching (control)
Number of subjects: 75
Study 32770831 — intervention group
Group type: EXPERIMENTAL
Intervention: CBDV (400 mg/day)
Number of subjects: 32
Study 32770831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 32141781 — intervention group
Group type: EXPERIMENTAL
Intervention: GAT IOP measurement in sitting and left lateral decubitus positions for PXFG non-operated patients
Number of subjects: 79
Study 32141781 — intervention group
Group type: EXPERIMENTAL
Intervention: GAT IOP measurement in sitting and left lateral decubitus positions for POAG non-operated patients
Number of subjects: 79
Study 32141781 — intervention group
Group type: EXPERIMENTAL
Intervention: GAT IOP measurement in sitting and left lateral decubitus positions for PXFG operated patients
Number of subjects: 79
Study 32141781 — intervention group
Group type: EXPERIMENTAL
Intervention: GAT IOP measurement in sitting and left lateral decubitus positions for POAG operated patients
Number of subjects: 79
Study 32141781 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of GAT and Tonopen XL IOP measurements in LLDP
Number of subjects: 79
Study 36121651 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 208
Study 34070866 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-up with cloth facemask (EXP)
Number of subjects: 17
Study 34070866 — intervention group
Group type: COMPARATOR
Intervention: Warm-up without facemask (CON)
Number of subjects: 17
Study 34325355 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacarpal gloves
Number of subjects: 0
Study 36012890 — intervention group
Group type: EXPERIMENTAL
Intervention: HPI monitoring
Number of subjects: 76
Study 36012890 — intervention group
Group type: COMPARATOR
Intervention: Non-HPI
Number of subjects: 76
Study 33420287 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-dose posttransplant cyclophosphamide (20 mg/kg for MSD-PTCy cohort, 25 mg/kg for haplo-PTCy cohort) on days +3, +4 combined with cotransplantation of peripheral blood stem cells (PBSCs) and human umbilical cord-derived mesenchymal stem cells (UC-MSCs)
Number of subjects: 35
Study 33420287 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-dose posttransplant cyclophosphamide (20 mg/kg for MSD-PTCy cohort, 25 mg/kg for haplo-PTCy cohort) on days +3, +4 combined with cotransplantation of PBSCs and UC-MSCs
Number of subjects: 35
Study 32006484 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary augmented trabeculectomy
Number of subjects: 453
Study 32006484 — intervention group
Group type: COMPARATOR
Intervention: Primary medical management
Number of subjects: 453
Study 35143617 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical revascularization
Number of subjects: 353
Study 35143617 — intervention group
Group type: COMPARATOR
Intervention: Conservative arm of ISCHEMIA
Number of subjects: 353
Study 35143617 — intervention group
Group type: COMPARATOR
Intervention: Revascularization arm of ISCHEMIA
Number of subjects: 353
Study 35143617 — intervention group
Group type: COMPARATOR
Intervention: Invasive arm of ISCHEMIA
Number of subjects: 353
Study 33819238 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured exercise programme (5 weeks) including aerobics, stabilization, and pelvic floor muscle training
Number of subjects: 16
Study 33819238 — intervention group
Group type: COMPARATOR
Intervention: Postural education (Control)
Number of subjects: 16
Study 36444391 — intervention group
Group type: EXPERIMENTAL
Intervention: CHECC‐uP intervention (cervical cancer brochure plus 30-60 min health literacy-focused education followed by monthly phone counselling and navigation assistance for 6 months)
Number of subjects: 123
Study 36444391 — intervention group
Group type: COMPARATOR
Intervention: Control group (cervical cancer brochure)
Number of subjects: 123
Study 36444391 — intervention group
Group type: EXPERIMENTAL
Intervention: CHECC‐uP intervention
Number of subjects: 123
Study 32440723 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated stent (DCS)
Number of subjects: 278
Study 32440723 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 278
Study 32861197 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Mediterranean ketogenic diet (MMKD)
Number of subjects: 17
Study 32861197 — intervention group
Group type: COMPARATOR
Intervention: American Heart Association Diet (AHAD)
Number of subjects: 17
Study 35032578 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped Care TF-CBT (SC-TF-CBT)
Number of subjects: 183
Study 35032578 — intervention group
Group type: COMPARATOR
Intervention: Standard TF-CBT
Number of subjects: 183
Study 34029521 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU 4 times per day for 8 weeks)
Number of subjects: 21
Study 34029521 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 32826014 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio-tape® (KT)
Number of subjects: 7
Study 32826014 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 7
Study 32826014 — intervention group
Group type: COMPARATOR
Intervention: No tape (NT)
Number of subjects: 7
Study 36058058 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 kcal/ml enteral formula
Number of subjects: 80
Study 36058058 — intervention group
Group type: COMPARATOR
Intervention: 1.0 kcal/ml enteral formula
Number of subjects: 80
Study 34154344 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) combined with transcranial direct current stimulation (tDCS)
Number of subjects: 60
Study 34154344 — intervention group
Group type: COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS)
Number of subjects: 60
Study 34154344 — intervention group
Group type: COMPARATOR
Intervention: Traditional Chinese medicine (TCM)
Number of subjects: 60
Study 34969649 — intervention group
Group type: EXPERIMENTAL
Intervention: Core muscle functional strength training (CMFST) for 12 weeks
Number of subjects: 588
Study 34969649 — intervention group
Group type: COMPARATOR
Intervention: Control group (no extra training)
Number of subjects: 588
Study 32020044 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard chemotherapy with lenalidomide (20 mg/day for days 1-21)
Number of subjects: 222
Study 32020044 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy without lenalidomide
Number of subjects: 222
Study 32020044 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard chemotherapy with lenalidomide
Number of subjects: 222
Study 36410482 — intervention group
Group type: EXPERIMENTAL
Intervention: Point of use (POU) arsenic filter with 3 calls promoting filter use (mHealth and filter only arm)
Number of subjects: 50
Study 36410482 — intervention group
Group type: EXPERIMENTAL
Intervention: Point of use (POU) arsenic filter with 3 calls promoting filter use, 3 in-person home visits, and 3 Facebook messages (intensive arm)
Number of subjects: 50
Study 36410482 — intervention group
Group type: COMPARATOR
Intervention: Temporal variability in water arsenic concentrations
Number of subjects: 50
Study 32100224 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic combined training (12-week program, 3 days per week, including stretching, hydraulic resistance training, and cool-down)
Number of subjects: 58
Study 32100224 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic combined training
Number of subjects: 58
Study 32100224 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 58
Study 35168196 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-based intervention 3 times per week for 16 weeks
Number of subjects: 424
Study 35168196 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 424
Study 34367647 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group and interview discussions regarding trial design
Number of subjects: 17
Study 34367647 — intervention group
Group type: EXPERIMENTAL
Intervention: Waiver of consent
Number of subjects: 17
Study 34367647 — intervention group
Group type: EXPERIMENTAL
Intervention: General trial design discussions
Number of subjects: 17
Study 35772219 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent energy restriction (IER)
Number of subjects: 28
Study 35772219 — intervention group
Group type: COMPARATOR
Intervention: Continuous energy restriction (CER)
Number of subjects: 28
Study 33752647 — intervention group
Group type: EXPERIMENTAL
Intervention: MUR service (intervention group)
Number of subjects: 153
Study 32892376 — intervention group
Group type: EXPERIMENTAL
Intervention: Less invasive surfactant application (LISA)
Number of subjects: 156
Study 32892376 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal intubation
Number of subjects: 156
Study 32892376 — intervention group
Group type: EXPERIMENTAL
Intervention: Less invasive surfactant application (LISA) in infants born at 25 and 26 weeks of GA
Number of subjects: 156
Study 32892376 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal intubation in infants born at 25 and 26 weeks of GA
Number of subjects: 156
Study 33068348 — intervention group
Group type: EXPERIMENTAL
Intervention: Elongated needle group (needling depth 60‐73 mm)
Number of subjects: 70
Study 33068348 — intervention group
Group type: COMPARATOR
Intervention: Filiform needle group (needling depth 25‐30 mm)
Number of subjects: 70
Study 35265334 — intervention group
Group type: EXPERIMENTAL
Intervention: Cesarean delivery on maternal request (CDMR)
Number of subjects: 6972
Study 33596722 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyproheptadine (8 mg, competitive 5-HT2 antagonist)
Number of subjects: 10
Study 32215633 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone pretreatment plus misoprostol
Number of subjects: 300
Study 32215633 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol alone
Number of subjects: 300
Study 35422427 — intervention group
Group type: EXPERIMENTAL
Intervention: TD139 (0.3-10 mg once daily for 14 days)
Number of subjects: 24
Study 35422427 — intervention group
Group type: COMPARATOR
Intervention: TD139 (0.15-50 mg single doses)
Number of subjects: 24
Study 34599040 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide acetate (low, medium, and high doses)
Number of subjects: 0
Study 34599040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33516587 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0‐mm locking plating system
Number of subjects: 60
Study 33516587 — intervention group
Group type: COMPARATOR
Intervention: 2.0‐mm non-locking plating system
Number of subjects: 60
Study 32114729 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM‐CSF gel (10 mg per square centimeter, dressing change every 24 hours until complete healing)
Number of subjects: 45
Study 32114729 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM‐CSF gel
Number of subjects: 45
Study 32114729 — intervention group
Group type: COMPARATOR
Intervention: Control group (aloe vera gel, same treatment protocol)
Number of subjects: 45
Study 34240176 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 64
Study 34089483 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 688
Study 34089483 — intervention group
Group type: COMPARATOR
Intervention: Mechanical ventilation (MV)
Number of subjects: 688
Study 34059974 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) applied before implant bed preparation and after suturing (808-nm GaAlA laser, 80 seconds; 11J/cm2)
Number of subjects: 33
Study 34059974 — intervention group
Group type: COMPARATOR
Intervention: Control group (no LLLT)
Number of subjects: 33
Study 32162301 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesorectal excision with lateral lymph node dissection (ME with LLND)
Number of subjects: 701
Study 32162301 — intervention group
Group type: COMPARATOR
Intervention: Mesorectal excision alone (ME alone)
Number of subjects: 701
Study 33454232 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender essential oil inhalation (3 drops of 1.5% for 30 nights)
Number of subjects: 183
Study 33454232 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamomile essential oil inhalation (3 drops of 1.5% for 30 nights)
Number of subjects: 183
Study 33454232 — intervention group
Group type: COMPARATOR
Intervention: Control group (inhalation of distilled water for 30 nights)
Number of subjects: 183
Study 34311063 — intervention group
Group type: EXPERIMENTAL
Intervention: lnLAEI (log-transformed left atrial expansion index)
Number of subjects: 649
Study 34311063 — intervention group
Group type: EXPERIMENTAL
Intervention: lnLAEI cutoff < 4.02
Number of subjects: 649
Study 34311063 — intervention group
Group type: EXPERIMENTAL
Intervention: Equation PCWP = 38.3 − 6.2 × lnLAEI
Number of subjects: 649
Study 35230162 — intervention group
Group type: EXPERIMENTAL
Intervention: Bremelanotide 1.75 mg
Number of subjects: 1202
Study 35230162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1202
Study 36414783 — intervention group
Group type: EXPERIMENTAL
Intervention: One-shot cognitive behavioral therapy for insomnia (CBT-I)
Number of subjects: 57
Study 36414783 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 57